Terramed Alliance News Safe To Treat HER2-positive Breast Cancer

Standard adjuvant treatment for HER2-positive breast cancer patients, following primary surgery for their cancer, is Trastuzumab (Herceptin)–typically used in combination with chemotherapy. However, a new study by researchers at Fox Chase Cancer Center reports that it may be safe to treat these patients with both Trastuzumab and adjuvant radiation therapy.

The study will be presented at the annual meeting of the American Society for Radiation Oncology (ASTRO).

» Read more: Terramed Alliance News Safe To Treat HER2-positive Breast Cancer

Related posts

Tags:

Plant Programme

Product Description
Professor Jane Plant’s bestselling first book, Your Life in Your Hands, was aimed as those trying to treat or prevent breast or prostate cancer. In this book she and tellow scientist Gill Tidey show us how to make the necessary changes to implement the Plant Programme in our everyday life. From essential equipment in the kitchen, to weekly menu plans – delicious, nutritious, easy to prepare and mostly inexpensive – to food for the kids, The Plant Programme can be be… More >>

» Read more: Plant Programme

Tags:

Terramed Alliance News Moderate Alcohol Consumption Increases Risk of Cancer in Women

The best “treatment” for cancer is to prevent it from occurring. Research is ongoing to evaluate environmental and lifestyle factors that may be associated with an increased incidence of cancer. Identifying such risk factors may allow individuals to modify lifestyle choices in order to reduce their risk of developing cancer.

The Million Women Study in the United Kingdom involved over 1.3 million middle-aged women who responded to a questionnaire regarding sociodemographic and personal information, including alcohol consumption. These women were followed for several years in an effort to determine how reproductive and lifestyle factors affect women’s health.

» Read more: Terramed Alliance News Moderate Alcohol Consumption Increases Risk of Cancer in Women

Related posts

Tags: